Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of non-β-lactams on stable variants of inhibitor-resistant TEM β-lactamase in uropathogenic Escherichia coli: implication for alternative therapy.

Journal of applied microbiology - 1 Mar 2018

Mukherjee S K, Mandal R S, Das S, Mukherjee M

Abstract excerpt

AIMS: β-lactamase inhibitor resistance (BLIR) among the uropathogenic Escherichia coli (UPEC) minimizes treatment options. This study aimed to identify inhibitor-resistant TEM (IRT) β-lactamase that impart BLIR phenotype and explore non-β-lactams as alternative therapeutics. METHODS AND RESULTS: Thirty BLIR UPEC isolates were detected by Kirby-Bauer disc diffusion technique using β-lactam-β-lactamase inhibitor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactam Resistance
Share to beta-Lactamase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to beta-Lactams

Share to Ceftazidime

Share to Cephalosporins

Share to Flavanones

Share to Molecular Docking Simulation

Share to Uropathogenic Escherichia coli

Source

Identifiers

PMID: 29247576
DOI: 10.1111/jam.13671

Genes

IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of non-β-lactams on stable variants of inhibitor-resistant TEM β-lactamase in uropathogenic Escherichia coli: implication for alternative therapy.PMID 29247576Read ↗

Identifications of multi-drug resistanturopathogens among infected patients from hospitals in Nablus-PalestineSemantic proximity Read ↗

Prevalence, mechanisms and comparison of detection methods of fosfomycin resistance in <i>E. coli</i> from urinary tract infectionsSemantic proximity Read ↗

Tackling the Antibiotic Resistance Caused by Class A β-Lactamases through the Use of β-Lactamase Inhibitory ProteinSemantic proximity Read ↗

Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coliSemantic proximity Read ↗

Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.Semantic proximity Read ↗

Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directionsSemantic proximity Read ↗

Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & NiazirinSemantic proximity Read ↗

Impact of Mutation on the Structural Stability and the Conformational Landscape of Inhibitor-Resistant TEM β-Lactamase: A High-Performance Molecular Dynamics Simulation Study.Semantic proximity Read ↗

The role of new β-lactamase inhibitors in gram-negative infectionsSemantic proximity Read ↗

Delineating the Role of mutation on the structural stability and conformational landscape of inhibitor-resistant TEMβ-lactamase: A high-performance molecular dynamics simulations StudySemantic proximity Read ↗

Prevalence of β-lactamase enzyme producing uropathogenic E.coli isolates amongst diabetic and non-diabetic patientsSemantic proximity Read ↗

Phenotypic and in silico studies for a series of synthetic thiosemicarbazones as New Delhi metallo-beta-lactamase carbapenemase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.